Welcome to Infectious Diseases and Epidemiology
The Department of Pediatrics Section of Infectious Diseases and Epidemiology provides clinical services at
Children's Hospital Colorado.
The Section of Infectious Diseases and Epidemiology is committed to educating and training medical students, physician assistants, residents, and fellows. Our faculty and fellows have won numerous teaching awards for their outstanding educational contributions.
Our Section has maintained an active and highly respected fellowship training program for the past 30 years. Our three-year ACGME fellowship training program provides comprehensive ID clinical experience in addition to broad research opportunities. Physicians who are board eligible in pediatrics will receive at least 12 months of in-depth training in the clinical and microbiological aspects of infectious diseases. This will include inpatient consulting, infectious diseases clinic, HIV clinic and infection control. At least 21 months will be devoted to research. Upon completion of the program fellows will be eligible for subspecialty boards.
Training for residents in pediatric infectious diseases is provided through clinical consultations to the ward team and outpatient clinics. A month-long elective provides a more intensive experience as an infectious diseases consultant and a brief period in the clinical microbiology laboratory.
Training for students begins with core lectures for third-years taking the pediatric clerkship. An elective in pediatric infectious diseases is available for fourth-year medical students who have completed a pediatric clerkship.
The Section of Infectious Diseases and Epidemiology has an active basic and translational research program with more than $5 million of federal funding yearly.
The Section has over 30 full-time faculty engaged in a broad range of research, including respiratory viral pathogens, enteric viral diseases, hospital epidemiology, international health, HIV, TB, Kawasaki disease, Staph toxin disease, and vaccine-preventable diseases. We participate in multiple national clinical trials of antiviral agents, antiretroviral medications, and vaccines.